Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1991 May;54(5):406–411. doi: 10.1136/jnnp.54.5.406

Actuarial analysis of the occurrence of remissions following thymectomy for myasthenia gravis in 400 patients.

L Durelli 1, G Maggi 1, C Casadio 1, R Ferri 1, S Rendine 1, L Bergamini 1
PMCID: PMC488538  PMID: 1865202

Abstract

The role of thymectomy in the treatment of myasthenia gravis (MG) was analysed in 400 patients affected with generalised MG operated on between 1974-83, and prospectively followed up for five years after surgery. The occurrence of stable remission (SR) (that is, complete clinical drug-free remission that remains stable for all the subsequent follow up) was the endpoint of survival analyses and the distribution of SR time (SRT, that is, the interval from thymectomy to the occurrence of SR) was assessed by actuarial and Cox multivariate analyses. SRT distribution after surgery showed a slow progressive increase of cumulative SR rate that could both be ascribed to a delayed effect of thymectomy as well as reflect the natural history of MG, itself characterised by an increasing probability of spontaneous remission with time. SRT distribution was similar after stratification for all variables studied except when patients without thymoma were stratified for the need for immunosuppressive treatment in addition to thymectomy. Patients without thymoma who did not require additional immunosuppressive therapy (n = 130) had the highest SR rate occurring in the two years after thymectomy, and differed from patients treated with immunosuppressive drugs who showed the highest SR rate five years after surgery. Actuarial analysis has therefore identified a subgroup of patients where SR, occurring in the first years after surgery, is more likely to be ascribed to thymectomy than merely reflect the natural course of the disease.

Full text

PDF
406

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERKSON J., GAGE R. P. Calculation of survival rates for cancer. Proc Staff Meet Mayo Clin. 1950 May 24;25(11):270–286. [PubMed] [Google Scholar]
  2. Bofill M., Janossy G., Willcox N., Chilosi M., Trejdosiewicz L. K., Newsom-Davis J. Microenvironments in the normal thymus and the thymus in myasthenia gravis. Am J Pathol. 1985 Jun;119(3):462–473. [PMC free article] [PubMed] [Google Scholar]
  3. Buckingham J. M., Howard F. M., Jr, Bernatz P. E., Payne W. S., Harrison E. G., Jr, O'Brien P. C., Weiland L. H. The value of thymectomy in myasthenia gravis: a computer-assisted matched study. Ann Surg. 1976 Oct;184(4):453–458. doi: 10.1097/00000658-197610000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Castleman B. The pathology of the thymus gland in myasthenia gravis. Ann N Y Acad Sci. 1966 Jan 26;135(1):496–505. doi: 10.1111/j.1749-6632.1966.tb45497.x. [DOI] [PubMed] [Google Scholar]
  5. Cohen M. S., Younger D. Aspects of the natural history of myasthenia gravis: crisis and death. Ann N Y Acad Sci. 1981;377:670–677. doi: 10.1111/j.1749-6632.1981.tb33765.x. [DOI] [PubMed] [Google Scholar]
  6. Drachman D. B. Present and future treatment of myasthenia gravis. N Engl J Med. 1987 Mar 19;316(12):743–745. doi: 10.1056/NEJM198703193161209. [DOI] [PubMed] [Google Scholar]
  7. Durelli L., Massazza U., Poccardi G., Ferrio M. F., Cavallo R., Maggi G., Casadio C., Di Summa M., Bergamini L. Increased thymocyte differentiation in myasthenia gravis: a dual-color immunofluorescence phenotypic analysis. Ann Neurol. 1990 Feb;27(2):174–180. doi: 10.1002/ana.410270213. [DOI] [PubMed] [Google Scholar]
  8. Emeryk B., Strugalska M. H. Evaluation of results of thymectomy in myasthenia gravis. J Neurol. 1976 Jan 14;211(2):155–168. doi: 10.1007/BF00313359. [DOI] [PubMed] [Google Scholar]
  9. Fraser K., Simpson J. A., Crawford J. The place of surgery in the treatment of myasthenia gravis. Br J Surg. 1978 May;65(5):301–304. doi: 10.1002/bjs.1800650503. [DOI] [PubMed] [Google Scholar]
  10. Fujii Y., Monden Y., Hashimoto J., Nakahara K., Kawashima Y. Acetylcholine receptor antibody-producing cells in thymus and lymph nodes in myasthenia gravis. Clin Immunol Immunopathol. 1985 Jan;34(1):141–146. doi: 10.1016/0090-1229(85)90018-2. [DOI] [PubMed] [Google Scholar]
  11. GROB D. Myasthenia gravis. A review of pathogenesis and treatment. Arch Intern Med. 1961 Oct;108:615–638. doi: 10.1001/archinte.1961.03620100107017. [DOI] [PubMed] [Google Scholar]
  12. Genkins G., Papatestas A. E., Horowitz S. H., Kornfield P. Studies in myasthenia gravis: early thymectomy. Electrophysiologic and pathologic correlations. Am J Med. 1975 Apr;58(4):517–524. doi: 10.1016/0002-9343(75)90125-4. [DOI] [PubMed] [Google Scholar]
  13. Grob D., Arsura E. L., Brunner N. G., Namba T. The course of myasthenia gravis and therapies affecting outcome. Ann N Y Acad Sci. 1987;505:472–499. doi: 10.1111/j.1749-6632.1987.tb51317.x. [DOI] [PubMed] [Google Scholar]
  14. Grob D., Brunner N. G., Namba T. The natural course of myasthenia gravis and effect of therapeutic measures. Ann N Y Acad Sci. 1981;377:652–669. doi: 10.1111/j.1749-6632.1981.tb33764.x. [DOI] [PubMed] [Google Scholar]
  15. Hammond S. R., English D. R., de Wytt C., Hallpike J. F., Millingen K. S., Stewart-Wynne E. G., McLeod J. G., McCall M. G. The contribution of mortality statistics to the study of multiple sclerosis in Australia. J Neurol Neurosurg Psychiatry. 1989 Jan;52(1):1–7. doi: 10.1136/jnnp.52.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Henze A., Biberfeld P., Christensson B., Matell G., Pirskanen R. Failing transcervical thymectomy in myasthenia gravis. An evaluation of transsternal re-exploration. Scand J Thorac Cardiovasc Surg. 1984;18(3):235–238. doi: 10.3109/14017438409109897. [DOI] [PubMed] [Google Scholar]
  17. Jaretzki A., 3rd, Bethea M., Wolff M., Olarte M. R., Lovelace R. E., Penn A. S., Rowland L. A rational approach to total thymectomy in the treatment of myasthenia gravis. Ann Thorac Surg. 1977 Aug;24(2):120–130. doi: 10.1016/s0003-4975(10)63720-4. [DOI] [PubMed] [Google Scholar]
  18. Jaretzki A., 3rd, Penn A. S., Younger D. S., Wolff M., Olarte M. R., Lovelace R. E., Rowland L. P. "Maximal" thymectomy for myasthenia gravis. Results. J Thorac Cardiovasc Surg. 1988 May;95(5):747–757. [PubMed] [Google Scholar]
  19. Kornstein M. J., Brooks J. J., Anderson A. O., Levinson A. I., Lisak R. P., Zweiman B. The immunohistology of the thymus in myasthenia gravis. Am J Pathol. 1984 Nov;117(2):184–194. [PMC free article] [PubMed] [Google Scholar]
  20. Lisak R. P., Levinson A. I., Zweiman B., Kornstein M. J. Antibodies to acetylcholine receptor and tetanus toxoid: in vitro synthesis by thymic lymphocytes. J Immunol. 1986 Aug 15;137(4):1221–1225. [PubMed] [Google Scholar]
  21. Masaoka A., Monden Y. Comparison of the results of transsternal simple, transcervical simple, and extended thymectomy. Ann N Y Acad Sci. 1981;377:755–765. doi: 10.1111/j.1749-6632.1981.tb33773.x. [DOI] [PubMed] [Google Scholar]
  22. Masaoka A., Monden Y., Seike Y., Tanioka T., Kagotani K. Reoperation after transcervical thymectomy for myasthenia gravis. Neurology. 1982 Jan;32(1):83–85. doi: 10.1212/wnl.32.1.83. [DOI] [PubMed] [Google Scholar]
  23. McQuillen M. P., Leone M. G. A treatment carol: thymectomy revisited. Neurology. 1977 Dec;27(12):1103–1106. doi: 10.1212/wnl.27.12.1103. [DOI] [PubMed] [Google Scholar]
  24. Monden Y., Nakahara K., Kagotani K., Fujii Y., Nanjo S., Masaoka A., Kawashima Y. Effects of preoperative duration of symptoms on patients with myasthenia gravis. Ann Thorac Surg. 1984 Sep;38(3):287–291. doi: 10.1016/s0003-4975(10)62253-9. [DOI] [PubMed] [Google Scholar]
  25. Mulder D. G., Herrmann C., Jr, Keesey J., Edwards H. Thymectomy for myasthenia gravis. Am J Surg. 1983 Jul;146(1):61–66. doi: 10.1016/0002-9610(83)90260-x. [DOI] [PubMed] [Google Scholar]
  26. Olanow C. W., Wechsler A. S., Sirotkin-Roses M., Stajich J., Roses A. D. Thymectomy as primary therapy in myasthenia gravis. Ann N Y Acad Sci. 1987;505:595–606. doi: 10.1111/j.1749-6632.1987.tb51328.x. [DOI] [PubMed] [Google Scholar]
  27. Oosterhuis H. J. Myasthenia gravis. A survey. Clin Neurol Neurosurg. 1981;83(3):105–135. doi: 10.1016/0303-8467(81)90014-7. [DOI] [PubMed] [Google Scholar]
  28. Oosterhuis H. J. Observations of the natural history of myasthenia gravis and the effect of thymectomy. Ann N Y Acad Sci. 1981;377:678–690. doi: 10.1111/j.1749-6632.1981.tb33766.x. [DOI] [PubMed] [Google Scholar]
  29. Osserman K. E., Genkins G. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med. 1971 Nov-Dec;38(6):497–537. [PubMed] [Google Scholar]
  30. Otto T. J., Strugalska H. Surgical treatment for myasthenia gravis. Thorax. 1987 Mar;42(3):199–204. doi: 10.1136/thx.42.3.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Paletto A. E., Maggi G. Thymectomy in the treatment of myasthenia gravis: results in 320 patients. Int Surg. 1982 Jan-Mar;67(1):13–16. [PubMed] [Google Scholar]
  32. Papatestas A. E., Genkins G., Kornfeld P. Comparison of the results of the transcervical and transsternal thymectomy in myasthenia gravis. Ann N Y Acad Sci. 1981;377:766–778. doi: 10.1111/j.1749-6632.1981.tb33774.x. [DOI] [PubMed] [Google Scholar]
  33. Papatestas A. E., Genkins G., Kornfeld P., Eisenkraft J. B., Fagerstrom R. P., Pozner J., Aufses A. H., Jr Effects of thymectomy in myasthenia gravis. Ann Surg. 1987 Jul;206(1):79–88. doi: 10.1097/00000658-198707000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Penn A. S., Jaretzki A., 3rd, Wolff M., Chang H. W., Tennyson V. Thymic abnormalities: antigen or antibody? Response to thymectomy in myasthenia gravis. Ann N Y Acad Sci. 1981;377:786–804. doi: 10.1111/j.1749-6632.1981.tb33776.x. [DOI] [PubMed] [Google Scholar]
  35. Perlo V. P., Arnason B., Poskanzer D., Castleman B., Schwab R. S., Osserman K. E., Papatestis A., Alpert L., Kark A. The role of thymectomy in the treatment of myasthenia gravis. Ann N Y Acad Sci. 1971 Sep 15;183:308–315. doi: 10.1111/j.1749-6632.1971.tb30761.x. [DOI] [PubMed] [Google Scholar]
  36. Perlo V. P., Poskanzer D. C., Schwab R. S., Viets H. R., Osserman K. E., Genkins G. Myasthenia gravis: evaluation of treatment in 1,355 patients. Neurology. 1966 May;16(5):431–439. doi: 10.1212/wnl.16.5.431. [DOI] [PubMed] [Google Scholar]
  37. Rowland L. P. Controversies about the treatment of myasthenia gravis. J Neurol Neurosurg Psychiatry. 1980 Jul;43(7):644–659. doi: 10.1136/jnnp.43.7.644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Rowland L. P. Therapy in myasthenia gravis: introduction. Ann N Y Acad Sci. 1987;505:566–567. doi: 10.1111/j.1749-6632.1987.tb51324.x. [DOI] [PubMed] [Google Scholar]
  39. SIMPSON J. A. An evaluation of thymectomy in myasthenia gravis. Brain. 1958 Mar;81(1):112–144. doi: 10.1093/brain/81.1.112. [DOI] [PubMed] [Google Scholar]
  40. Scadding G. K., Havard C. W., Lange M. J., Domb I. The long term experience of thymectomy for myasthenia gravis. J Neurol Neurosurg Psychiatry. 1985 May;48(5):401–406. doi: 10.1136/jnnp.48.5.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Scadding G. K., Vincent A., Newsom-Davis J., Henry K. Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology. Neurology. 1981 Aug;31(8):935–943. doi: 10.1212/wnl.31.8.935. [DOI] [PubMed] [Google Scholar]
  42. Simpson J. A., Thomaides T. Treatment of myasthenia gravis: an audit. Q J Med. 1987 Aug;64(244):693–704. [PubMed] [Google Scholar]
  43. Thomas J. A., Willcox H. N., Newsom-Davis J. Immunohistological studies of the thymus in myasthenia gravis. Correlation with clinical state and thymocyte culture responses. J Neuroimmunol. 1982 Dec;3(4):319–335. doi: 10.1016/0165-5728(82)90035-2. [DOI] [PubMed] [Google Scholar]
  44. Wekerle H., Hohlfeld R., Ketelsen U. P., Kalden J. R., Kalies I. Thymic myogenesis, T-lymphocytes and the pathogenesis of myasthenia gravis. Ann N Y Acad Sci. 1981;377:455–476. doi: 10.1111/j.1749-6632.1981.tb33753.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES